Press

Welcome to Our Press Section

Here you will find all our news releases, download materials and information on upcoming events.

Media Library

01.02.2022

Navigo Proteins Appoints Chris-Carol Bremer as Chief Development Officer

Download PDF

02.12.2021

ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therapy to Address Solid Tumors

Download PDF

07.10.2021

Navigo Proteins GmbH Announces Extension of Partnership with ITM for Targeted Radio Conjugates

Download PDF

09.09.2021

Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies

Download PDF

11.05.2021

Navigo Proteins and MDimune Enter into a Research Collaboration on Affilin®-Mediated Targeting of Extracellular Vesicles

Download PDF

16.03.2021

Navigo Proteins and Eleva Announce Successful Development of an Affinity Chromatography Resin Customized for the Efficient Production of Human Complement-Factor H

Download PDF

08.02.2021

Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines

Download PDF

04.08.2020

Navigo Proteins and Repligen Announce Achievement of a Key Milestone in Development of an Affinity Resin for the Purification of COVID-19Vaccines

Download PDF

27.04.2018

Repligen Announces Agreement with Navigo Proteins for the Exclusive Co-Development of Next Generation Affinity Ligands

Download PDF

12.01.2017

UV-Cap GmbH & Co KG acquires Scil Proteins GmbH Scil Proteins GmbH becomes Navigo Proteins GmbH

Download PDF

03.01.2016

ITM and Scil Proteins announce new Partnership for Targeted Radio Conjugates

Download PDF

Press Contacts

If you are a media representative (journalist, blogger, etc.) and need information about Navigo Proteins, Halle, Germany, please feel free to get in touch with our media contacts below.

info@navigo-proteins.com